Clinical trial Recruiting at 1 site Observational Ages 18 to 50 Women only

Identifying ureters during deep endometriosis surgery using indocyanine green dye instead of ureteric stents

Official title: Ureteric Identification Using Indocyanine Green Dye Versus Conventional Ureteric Stenting to Reduce Post-operative Pain and Surgical Morbidity During Endometriosis Surgery: A Pilot Trial (ICE Trial)

Run by University Hospitals of North Midlands NHS Trust · NCT06852248 · Data updated 2026-11-12

This project will see if injecting indocyanine green dye into the ureters causes less postoperative pain than placing ureteric stents for women aged 18–50 undergoing laparoscopic or robotic surgery for deep endometriosis.

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexWomen only
Enrollment70 (estimated)
SponsorUniversity Hospitals of North Midlands NHS Trust
Academic / other
Locations1 site (Stoke-on-Trent, Staffordshire)
StatusRecruiting
StartedJuly 29, 2025
Main results expectedMarch 2027
Study endsMarch 2028
Registry record updatedSeptember 3, 2025
Trial IDNCT06852248 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18–50 scheduled for laparoscopic or robotic excision of deep endometriosis where ureteric stenting is planned and who are able to give informed consent.

Probably not a fit

People who are pregnant, have suspected malignancy, prior ureteric injury, are medically unfit for surgery, or have a BMI over 45 are excluded and unlikely to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Surgeons often place temporary ureteric stents during excision of deep endometriosis to reduce the risk of ureteric injury, but stents can cause significant pain and blood in the urine. This observational feasibility project compares conventional ureteric stenting with injection of indocyanine green (ICG) dye to make ureters visible under near-infrared imaging. Investigators will record perioperative outcomes including postoperative pain, urinary symptoms, operative time, and surgical complications to determine whether the dye approach appears safe and acceptable. Results will be used to decide if a larger randomized trial is warranted.

Why it matters

Potential benefit: If successful, this technique could reduce stent-related pain and urinary symptoms after deep endometriosis surgery while keeping similar safety and surgical outcomes.

How similar studies have gone: Small surgical series and case reports have shown ICG can reliably highlight ureters and suggest fewer stent-related symptoms, but randomized or large comparative evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 18 to 50 years
* Scheduled for laparoscopic or robotic-assisted surgical excision of deep endometriosis (DE) where ureteric stenting is planned.
* Willing and able to provide consent for participation in the study

Exclusion Criteria:

* Confirmed or suspected pregnancy at the time of enrolment.
* Suspicion or confirmation of malignancy.
* History of ureteric injury from prior surgery or trauma
* Medically unfit for surgery due to the following conditions:

  * Uncontrolled diabetes mellitus.
  * Severe Chronic Obstructive Pulmonary Disease (COPD).
  * Hypertrophic cardiomyopathy or significant cardiac conditions (e.g., recent myocardial infarction, aortic stenosis).
  * History of stroke or severe kyphoscoliosis.
  * Uncontrolled hypertension.
* Body mass index (BMI): BMI greater than 45

Where it's running

  • University Hospitals of North Midlands NHS Trust
    Stoke-on-Trent, Staffordshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.